Aptamer Group, the developer of next-generation synthetic binders for the life sciences industry, has announced a new contract valued at up to £617,000 with a top-five pharmaceutical company.
Ardena, a pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointment of Dipesh Patel as chief quality officer and Peter Rose as chief information officer.
Rachel Houghton, managing director at Business Moves Group (BMG), explores how pharmaceutical manufacturers can navigate complex regulatory landscapes and safeguard sensitive equipment to ensure seamless international workplace transitions.
Aenova, a contract development and manufacturing organisation (CDMO), announces an investment in its sterile manufacturing capabilities with the installation of another fill & finish (F&F) line at its Latina site.
Hovione, a fully-integrated global CDMO, has announced the completion of an initial multi-million-dollar investment cycle to expand its manufacturing campus in East Windsor, New Jersey.
Sharp Services, a company in pharmaceutical packaging, clinical trial services & sterile manufacturing has announced a $100 million investment across its global facility network to address increasing market demand for established and new medicines.
ACG, the world’s most integrated provider of solid-dosage solutions, has announced a $200 million phased investment to establish its first empty-capsule manufacturing operations in the United States.
Agarose Bead Technologies (ABT), a manufacturer of high-quality agarose resins has today announced plans for further expansion, reinforcing its position as a strategic partner for biopharmaceutical companies developing next-generation therapies.
Teknomek has agreed a partnership with Monmouth Scientific to offer customers a range of containment cabinets which are designed to ensure safe handling of hazardous chemicals.
Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster.
ACD/Labs, an informatics company that develops and commercialises software in support of R&D, and Covestro have joined forces to bring AI-powered solvent recommendation capabilities to the Percepta platform.
NNIT has announced that its European division has secured another project with a long-term strategic partner to support the implementation of a solution from a provider of digital solutions for the life sciences industry.
